(288 days)
Not Found
No
The device description and performance studies focus on the physical components and standard bench/biocompatibility testing of a disposable insulin syringe, with no mention of AI or ML capabilities.
No
The device is a syringe used for administering insulin, which is a drug. It is a delivery tool, not a therapeutic agent itself.
No
The device is an insulin syringe used for subcutaneous injection, which is a delivery mechanism for medication, not for diagnosing conditions or diseases.
No
The device description clearly outlines physical components like a barrel, plunger, gasket, cap, and needle, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "subcutaneous injection of U-100 insulin." This describes a device used to administer a substance into the body, not to perform a diagnostic test on a sample taken from the body.
- Device Description: The description details a syringe, plunger, needle, etc., which are components of a device used for injection, not for in vitro diagnostic testing.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, or any process related to diagnosing a condition or monitoring a physiological state outside of the body.
- Performance Studies: The performance studies focus on the physical and biological safety of the syringe for injection (particulate matter, biocompatibility), not on the accuracy or reliability of a diagnostic test.
In summary, the SUNGSHIM® Sterile single use Insulin Syringe is a medical device for administering medication, not for performing in vitro diagnostic tests.
N/A
Intended Use / Indications for Use
SUNGSHIM® Sterile single use Insulin Syringe is hypodermic insulin syringe for subcutaneous injection of U-100 insulin. (Unit scale : U-100)
Product codes
FMF
Device Description
SUNGSHIM® Sterile single use Insulin Syringe is a disposable, single use syringe which consists of a calibrated hollow barrel, plunger, gasket, cap and fixed needle is a fixed and the needle cap is intended to provide physical protection to the needle. The cap is color coded orange for U-100 insulin, same as equivalent insulin syringes. The SUNGSHIM Sterile single is available in 0.5ml/cc and 1ml/cc sizes in gauges 28g to 31g.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Bench test: Test standard : ISO 8537:2007 Sterile single-use syringes, with or without needle, for insulin.
Particulate matter in injections: Test standard : USP Test item : Particulate matter in injections.
Biocompatibility: Category : External communicating device Contact : Blood path, indirect Contact duration : A-limited (≤24h). Test standard : ISO 10993-1, ISO 10993-4, ISO 10993-10, ISO 10993-10, ISO 10993-11, USP 39. Test item : Cytotoxicity, In vitro hemolysis, Acute systemic toxicity, Skin sensitization, Intracutaneous reactivity, Endotoxin.
The performance tests demonstrated that SUNGSHIM® Sterile single-use Insulin Syringe is as safe, as effective and performs in a substantially equivalent manner to the predicate device.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5860 Piston syringe.
(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized image of three faces in profile, stacked on top of each other. The faces are black and are oriented to the right. The logo is surrounded by a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in black.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 12, 2016
Sung Shim Medicare Co., Ltd. c/o Mr. Peter Chung Plus Global 300 Atwood St. Pittsburgh, Pennsylvania 15213
Re: K152803
Trade/Device Name: SUNGSHIM® Sterile Single Use Insulin Syringe Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: II Product Code: FMF Dated: April 14, 2016 Received: April 20, 2016
Dear Mr. Chung:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Image /page/1/Picture/8 description: The image contains a signature followed by the name "Tina Kiang". Below the name is the letter "S" with a dash in front of it. In the background, the letters "FDA" are faintly visible.
for Erin I. Keith, M.S Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K152803
Device Name
SUNGSHIM® Sterile single use Insulin Syringe
Indications for Use (Describe) SUNGSHIM® Sterile single use Insulin Syringe is hypodermic insulin syringe for subcutaneous injection of U-100 insulin. (Unit scale : U-100)
Type of Use (Select one or both, as applicable)
_ Prescription Use (Part 21 CFR 801 Subpart D)
മി Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW *
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
3
510(k) Summary (K152803) [as required by 807.92(c)]
1. Applicant
-
- Company : Sung Shim Medicare Co.,Ltd.
-
- Address : 190, Maesil-ro, Sojeong-myeon, Sejong-si, Korea
-
- Tel : 82-32-676-7066
-
- Fax : 82-32-676-7063
-
- Prepared date : July 12, 2016
-
- Contact person : Peter Chung, 412-687-3976
-
- Contact person address : 300 Atwood Street, Pittsburgh, PA, 15213, USA
2. Device Information
-
- Trade name : SUNGSHIM® Sterile single use Insulin Syringe
-
- Common name : Syringe, piston
-
- Classification name : Piston syringe
-
- Product code : FMF
-
- Requlation number : 880.5860
-
- Class of device : Class II
-
- Panel : General Hospital
-
- Model codes : Insulin Syringe 0.5ml/cc, Insulin Syringe 1ml/cc
3. The legally marketed device to which we are claiming equivalence
K070917 Feel-ject Insulin Syringe
4. Device description
SUNGSHIM® Sterile single use Insulin Syringe is a disposable, single use syringe which consists of a calibrated hollow barrel, plunger, gasket, cap and fixed needle is a fixed and the needle cap is intended to provide physical protection to the needle. The cap is color coded orange for U-100 insulin, same as equivalent insulin syringes. The SUNGSHIM Sterile single is available in 0.5ml/cc and 1ml/cc sizes in gauges 28g to 31g.
5. Intended Use :
SUNGSHIM® Sterile single use Insulin Syringe is hypodermic insulin syringe for subcutaneous injection of U-100 insulin. (Unit scale : U-100)
6. Performance data:
-
(1) Bench test
Test standard : ISO 8537:2007 Sterile single-use syringes, with or without needle, for insulin -
(2) Particulate matter in injections Test standard : USP Test item : Particulate matter in injections
-
(3) Biocompatibility
Category : External communicating device Contact : Blood path, indirect Contact duration : A-limited (≤24h)
Test standard : ISO 10993-1, ISO 10993-4, ISO 10993-10, ISO 10993-10, ISO 10993-11, USP 39
4
Test item : Cytotoxicity, In vitro hemolysis, Acute systemic toxicity, Skin sensitization, Intracutaneous reactivity, Endotoxin
The performance tests demonstrated that SUNGSHIM® Sterile single-use Insulin Syringe is as safe, as effective and performs in a substantially equivalent manner to the predicate device.
| Manufacturer | Sung Shim Medicare Co.,Ltd. | Feel Tech | ||
|---|---|---|---|---|
| 510(k) No. | K152803 | K070917 | ||
| Indication for use | SUNGSHIM® Sterile single use Insulin | |||
| Syringe is hypodermic insulin syringe for | ||||
| subcutaneous injection of U-100 insulin. (Unit | ||||
| scale : U-100) | The Feel-ject disposable sterile insulin | |||
| syringes are intended for injection of U100 | ||||
| insulin only. | ||||
| Product name | Syringe, piston | Syringe, piston | ||
| Trade name | SUNGSHIM® Sterile single use Insulin Syringe | Feel-ject Insulin syringe | ||
| Model/type | Insulin syringe 0.5ml/cc | |||
| Insulin syringe 1ml/cc | FIS-1001 1.0ml | |||
| FIS-0502 0.5ml | ||||
| Appearance | Image: Insulin syringe | Image: Insulin syringe | ||
| Product | ||||
| configuration | Barrel | |||
| Plunger | ||||
| Cap | ||||
| Gasket | ||||
| Needle | Barrel | |||
| Plunger | ||||
| Cap | ||||
| Gasket | ||||
| Needle | ||||
| Material | Part | Material | Part | Material |
| Barrel | Polypropylene | Barrel | Polypropylene | |
| Plunger | Polypropylene | Plunger | Polypropylene | |
| Cap | Polyethylene | Cap | Polyethylene | |
| Gasket | Rubber | Gasket | Rubber | |
| Needle | Stainless steel STS304 | Needle | Stainless steel STS 304 | |
| Length of parts (mm) : 1.0mL | ||||
| Total length of | ||||
| assembly | 118.2±2 | 116±2 | ||
| Side length of | ||||
| assembly(max) | 19.2±1 | 19.2±1 | ||
| Inner diameter of | ||||
| barrel | 4.74±0.3 | 4.7±0.3 | ||
| Out diameter of | ||||
| barrel | 7.0±0.3 | 6.6±0.3 | ||
| Scale of syringe | 1mL | 1mL | ||
| Gauge | 28G, 29G, 30G, 31G | 28G, 29, 30, 31G | ||
| Length of needle | 8 mm, 12.7 mm | 5 mm, 8 mm, 12.7 mm | ||
| Sterilization | EO Gas sterilization | EO Gas sterilization |
7. Predicate device comparison table
Although the Indications for Use is not identical to that of the predicate device it does not change the intended use because both are single use insulin syringes intended for the injection of U-100 insulin.
8. Conclusion:
The materials, performance and features of both the subject device and the predicate device are considered to be substantially equivalent.